The Food and Drug Administration's (FDA or Agency) Center for Drug Evaluation and Research, Professional Affairs and Stakeholder Engagement Staff (PASES), is hosting a 1-day public symposium entitled ``Safe Use Symposium: A Focus on Reducing Preventable Harm From Drugs in the Outpatient Setting.'' The purpose of this symposium is to discuss sources of preventable harm from drugs in the outpatient setting and to stimulate the exchange of ideas among thought leaders on interventions to reduce preventable harms and how these interventions can be studied.
Document
Safe Use Symposium: A Focus on Reducing Preventable Harm From Drugs in the Outpatient Setting
The Food and Drug Administration's (FDA or Agency) Center for Drug Evaluation and Research, Professional Affairs and Stakeholder Engagement Staff (PASES), is hosting a 1-day pub...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
82 FR 18910
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Safe Use Symposium: A Focus on Reducing Preventable Harm From Drugs in the Outpatient Setting,” thefederalregister.org (April 24, 2017), https://thefederalregister.org/documents/2017-08182/safe-use-symposium-a-focus-on-reducing-preventable-harm-from-drugs-in-the-outpatient-setting.